Lymph node surgery study for early-stage lung cancer in the upper lung
Part of Cancer clinical trials.
This trial tests whether a more focused lymph node removal during surgery is safe and effective for people with a small, early-stage lung cancer (non-small cell type) located in the top part of the lung (apical segment).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have not had any prior lung cancer surgery, chemotherapy, or radiation.
- Your cancer is a small, early-stage tumor (cT1N0M0) located in the top segment of the lung.
- The tumor has a ground-glass component (CTR > 0.5) on your CT scan.
- During surgery, the frozen section shows a type of lung cancer called non-lepidic predominant invasive NSCLC.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a lung-sparing surgery called segmentectomy for people with a certain type of lung cancer nodule. It aims to see if this surgery is a good option for those with solid-dominant nodules that are 2 to 3 cm in size and have not spread to lymph nodes.
This trial compares two types of lung surgery—removing a small lung segment versus removing an entire lung lobe—for small lung adenocarcinoma (≤ 2 cm). It may help you choose the safest approach that still controls the cancer.
This trial compares two types of surgery for early-stage lung cancer tumors that are 2-3 cm in size: removing just the affected segment of the lung (segmentectomy) or removing the entire lobe (lobectomy). It aims to see if the smaller surgery works just as well and may help you recover faster.
This trial tests if a smaller surgery (sublobar resection) works well for patients with very early-stage lung cancer (adenocarcinoma in situ or minimally invasive adenocarcinoma) that is found during the operation. It may help avoid removing more lung tissue than necessary.
This study compares a lung surgery approach (segmentectomy) for people with early, invasive lung cancer that shows “ground-glass” on scans. It aims to see if this less extensive surgery can treat the cancer effectively when the tumor is in a specific size and scan pattern range.
This study looks at certain lymph nodes removed during surgery for non-small cell lung cancer (NSCLC) that has grown into the covering of the lung. The goal is to better understand lymph node involvement and help guide future treatment decisions.
Hear when a new Lymph Node Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.